Popa M, Gurzu I, Mindru D, Gurzu B, Handra C, Eva-Maria E
Healthcare (Basel). 2025; 13(5).
PMID: 40077125
PMC: 11899654.
DOI: 10.3390/healthcare13050563.
Alshagrawi S, Hazazi A
Hum Vaccin Immunother. 2025; 21(1):2477954.
PMID: 40068961
PMC: 11901379.
DOI: 10.1080/21645515.2025.2477954.
Gao Q, Yang H, Yu Z, Wang Q, Wang S, Zhan B
Ann Med. 2024; 57(1):2443565.
PMID: 39711429
PMC: 11703302.
DOI: 10.1080/07853890.2024.2443565.
Alam M, Salauddin A, Moni S, Limon M, Musarrat R, Bosu S
Heliyon. 2024; 10(23):e40638.
PMID: 39654774
PMC: 11626022.
DOI: 10.1016/j.heliyon.2024.e40638.
Kim H, Son H
Trop Med Int Health. 2024; 29(12):1018-1025.
PMID: 39505688
PMC: 11613300.
DOI: 10.1111/tmi.14055.
Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands.
Pijnacker R, Mughini-Gras L, Verhoef L, van den Beld M, Franz E, Friesema I
Epidemiol Infect. 2024; 152:e130.
PMID: 39434376
PMC: 11502420.
DOI: 10.1017/S0950268824000815.
Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.
Fallahi M, Nazemi M, Zeighami A, Shahriarirad R
BMC Infect Dis. 2024; 24(1):1043.
PMID: 39333984
PMC: 11430532.
DOI: 10.1186/s12879-024-09947-0.
Impact of the COVID-19 Pandemic on Influenza Hospital Admissions and Deaths in Wales: Descriptive National Time Series Analysis.
Alsallakh M, Adeloye D, Vasileiou E, Sivakumaran S, Akbari A, Lyons R
JMIR Public Health Surveill. 2024; 10():e43173.
PMID: 39171430
PMC: 11358661.
DOI: 10.2196/43173.
Epidemiological Characteristics and Trends of Scarlet Fever in Zhejiang Province of China: Population-Based Surveillance during 2004-2022.
Fang Z, Ma C, Xu W, Shi X, Liu S
Can J Infect Dis Med Microbiol. 2024; 2024:6257499.
PMID: 39036471
PMC: 11260510.
DOI: 10.1155/2024/6257499.
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.
Clark J, Penrice-Randal R, Sharma P, Dong X, Pennington S, Marriott A
Viruses. 2024; 16(6).
PMID: 38932155
PMC: 11209060.
DOI: 10.3390/v16060863.
Impact of COVID-19 pandemic responses on tuberculosis incidence: insights from Shantou, China.
Su Y, Chang Q, Chen R, Chen Z, Lin J, Fu H
BMC Public Health. 2024; 24(1):1454.
PMID: 38816699
PMC: 11140913.
DOI: 10.1186/s12889-024-18956-2.
Changes in seasonal respiratory viral infections among pediatric population around the COVID-19 pandemic; 2019-2023.
Alzaydi M, Alosaimi A, Alghamdi A, Bamogaddam I, Altassan M, Almazrua A
Eur J Clin Microbiol Infect Dis. 2024; 43(8):1589-1596.
PMID: 38814498
DOI: 10.1007/s10096-024-04860-5.
Dynamics of respiratory infectious diseases under rapid urbanization and COVID-19 pandemic in the subcenter of Beijing during 2014-2022.
Guo C, Zhang W, Zhou Y, Zhang S, Xi L, Zheng R
Heliyon. 2024; 10(9):e29987.
PMID: 38737278
PMC: 11088252.
DOI: 10.1016/j.heliyon.2024.e29987.
Epidemic features and megagenomic analysis of childhood post COVID-19 pandemic: a 6-year study in southern China.
Xu Y, Yang C, Sun P, Zeng F, Wang Q, Wu J
Emerg Microbes Infect. 2024; 13(1):2353298.
PMID: 38721691
PMC: 11212572.
DOI: 10.1080/22221751.2024.2353298.
Use of Sentinel Surveillance Platforms for Monitoring SARS-CoV-2 Activity: Evidence From Analysis of Kenya Influenza Sentinel Surveillance Data.
Owusu D, Ndegwa L, Ayugi J, Kinuthia P, Kalani R, Okeyo M
JMIR Public Health Surveill. 2024; 10:e50799.
PMID: 38526537
PMC: 11002741.
DOI: 10.2196/50799.
Norovirus in children under 2 years of age: an epidemiological study in Panama during the COVID-19 pandemic.
DeAntonio R, Hess-Holtz M, Abrego L, Capitan-Barrios Z, Donoso L, De Leon T
Front Pediatr. 2024; 12:1292967.
PMID: 38425667
PMC: 10902054.
DOI: 10.3389/fped.2024.1292967.
The Characteristics of the Influenza Virus Epidemic Around the SARS-CoV-2 Epidemic Period in the Pudong New Area of Shanghai.
Zhang G, Zhang A, Zhang L, Zhu A, Li Z, Zhu W
J Epidemiol Glob Health. 2024; 14(2):304-310.
PMID: 38381354
PMC: 11176117.
DOI: 10.1007/s44197-024-00194-9.
Alleviation of PM2.5-associated Risk of Daily Influenza Hospitalization by COVID-19 Lockdown Measures: A Time-series Study in Northeastern Thailand.
Roudreo B, Puangthongthub S
J Prev Med Public Health. 2024; 57(2):108-119.
PMID: 38374709
PMC: 10999304.
DOI: 10.3961/jpmph.23.349.
Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.
Huang Q, Turner N, Wood T, Anglemyer A, McIntyre P, Aminisani N
Influenza Other Respir Viruses. 2024; 18(2):e13247.
PMID: 38350715
PMC: 10864123.
DOI: 10.1111/irv.13247.
Mapping trends and hotspots in research on global influenza vaccine hesitancy: A bibliometric analysis.
Zhang Z, Tang S, Huang Z, Tan J, Wu X, Hong Q
Health Sci Rep. 2024; 7(2):e1820.
PMID: 38323124
PMC: 10845823.
DOI: 10.1002/hsr2.1820.